A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome (PCOS) Interventions: Drug: Placebo; Drug: Pioglitazone; Drug: Spironolactone; Drug: Metformin Sponsor: Fundació Sant Joan de Déu Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Clinical Trials | Fortamet | Metformin | Ovaries | Polycystic Ovary Syndrome | Research | Spironolactone